Pulmatrix, Inc. (PULM) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time PULM price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 42.5 Neutral
Market Cap $5.8M
Volume 5.8K
Fundamentals — 10-Q Q1 2026
Revenue --
Net Income $-1.2M
EPS $-0.32
P/E Ratio -5.0x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Polaris Venture Partners Entrepreneurs Fund IV LP | 10% Owner | Buy | 1,150,000 | $0.00 | $0 | 2018 Apr 3 |
| Iwicki Mark T | Director | Buy | 307,000 | $0.00 | $0 | 2018 Apr 3 |
| Arch Venture Fund VII LP | Insider | Buy | 1,150,000 | $0.00 | $0 | 2018 Apr 3 |
| Sherman Matthew L | Director | Buy | 20,000 | $0.00 | $0 | 2018 Apr 3 |
| Oculus Innovative Sciences, Inc. | 10% Owner | Sell | 1,650,000 | $2.75 | $4.5M | 2015 Jun 17 |
| Rocklage Scott M | Director | Buy | 38,805 | $6.88 | $266,978 | 2015 Jun 16 |
| Arch Venture Fund VII LP | 10% Owner | Buy | 72,750 | $6.88 | $500,520 | 2015 Jun 16 |
| Maki David | Director | Buy | 72,750 | $6.88 | $500,520 | 2015 Jun 16 |
| Polaris Venture Partners V, L.P. | 10% Owner | Buy | 106,693 | $6.88 | $734,048 | 2015 Jun 15 |
Other Pharmaceutical Stocks
Take PULM further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put PULM in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Pulmatrix, Inc. next reports.
Set alerts on PULM
Get notified when Pulmatrix, Inc. hits your price targets or technical conditions are met.
Get Started Free